Summit Therapeutics (SMMT) Stock
Summit Therapeutics (SMMT) closed at $14.15 on Nov 13, 2026; its Tenet Score is 27 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $14.15
- Nov 13, 2026
- Market cap
- $9.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 12.07 – 29.23
- low → high
- Tenet Score
- 27/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Summit Therapeutics Inc scores 27/100. Weak. Strongest on financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 27 is built from 3 of 4 pillars, from 30% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
- ✕ Quality Floor
- ~ Qualified Dip
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI).…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Elanco Animal Health IncELAN | 38 | $13.4B |
| Bio-Techne CorpTECH | 53 | $11.4B |
| Halozyme Therapeutics Inc.HALO | 68 | $11.4B |
| Biomarin Pharmaceutical Inc.BMRN | 51 | $11.1B |
| Kymera Therapeutics IncKYMR | 44 | $10.9B |
| Repligen Corp.RGEN | 47 | $10.7B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.9B |
| Spyre Therapeutics Inc.SYRE | 44 | $9.9B |
| TG Therapeutics IncTGTX | 45 | $9.9B |
| Praxis Precision Medicines IncPRAX | 46 | $9.2B |
Common questions
What sector and industry is Summit Therapeutics in?
Summit Therapeutics is in the Healthcare sector and the Drugs industry.
What is Summit Therapeutics' Tenet Score?
Summit Therapeutics' Tenet Score is 27 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




